Kite Pharma

YESCARTA

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / YESCARTA – Q2041

Manufacturer:

Kite Pharma

Name:

YESCARTA

HCPCS Code Descriptor:

Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Category:

Q Code

HCPCS:

Q2041

NDC(s):

71287-0119-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

YESCARTA is an Oncology drug manufactured by Kite Pharma and administered via the Intravenous route of administration. The Q Code: Q2041 is aligned to the drug YESCARTA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/18

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Axicabtagene ciloleucel car+

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.kitekonnect.com/